SWOG
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1956-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.swog.org
S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer
- Conditions
- Esophageal Cancer
- Interventions
- Biological: cetuximab
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2018-09-26
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 63
- Registration Number
- NCT00096031
- Locations
- 🇺🇸
Piedmont Hospital, Atlanta, Georgia, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸Charles B. Eberhart Cancer Center at DeKalb Medical Center, Decatur, Georgia, United States
S0344 Intralesional Resection in Treating Patients With Chondrosarcoma of the Bone
- Conditions
- Sarcoma
- Interventions
- Procedure: conventional surgery
- First Posted Date
- 2004-11-09
- Last Posted Date
- 2012-01-18
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 60
- Registration Number
- NCT00096213
- Locations
- 🇺🇸
Presbyterian Hospital of Dallas, Dallas, Texas, United States
🇺🇸Group Health Central Hospital, Seattle, Washington, United States
🇺🇸University Cancer Center at University of Washington Medical Center, Seattle, Washington, United States
S0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck Cancer
- Conditions
- Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the LarynxRecurrent Squamous Cell Carcinoma of the OropharynxRecurrent Squamous Cell Carcinoma of the Lip and Oral Cavity
- First Posted Date
- 2004-11-08
- Last Posted Date
- 2013-11-08
- Lead Sponsor
- SWOG Cancer Research Network
- Registration Number
- NCT00095641
S9806: Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2004-09-13
- Last Posted Date
- 2012-10-08
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 204
- Registration Number
- NCT00003587
- Locations
- 🇺🇸
CCOP - Montana Cancer Consortium, Billings, Montana, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, California, United States
SWOG-9507, Fenretinide in Treating Patients With Neoplasia of the Mouth
- First Posted Date
- 2004-09-10
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 5
- Registration Number
- NCT00003223
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Detroit, Detroit, Michigan, United States
🇺🇸University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan, United States
🇺🇸Arizona Cancer Center, Tucson, Arizona, United States
S0229, Pulmonary Rehabilitation Education w/wo Exercise Training in Improving Physical Function in Patients Who Are Undergoing Chemo & RT for Locally Advanced Lung Cancer
- Conditions
- Lung CancerPulmonary Complications
- Interventions
- Other: educational interventionOther: supervised exercise program
- First Posted Date
- 2004-09-08
- Last Posted Date
- 2012-11-01
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 2
- Registration Number
- NCT00090961
- Locations
- 🇺🇸
Hematology-Oncology Centers of the Northern Rockies - Billings, Billings, Montana, United States
🇺🇸Decatur Memorial Hospital Cancer Care Institute, Decatur, Illinois, United States
🇺🇸Cardinal Bernardin Cancer Center at Loyola University Medical Center, Maywood, Illinois, United States
SWOG-9451, Combination Chemo & RT For Patients With Stage III/Stage IV Cancer of the Hypopharynx or Tongue
- Conditions
- Head and Neck Cancer
- Interventions
- Drug: Induction chemotherapyRadiation: low-LET cobalt-60 gamma ray therapy
- First Posted Date
- 2004-09-01
- Last Posted Date
- 2015-09-30
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 68
- Registration Number
- NCT00002735
- Locations
- 🇺🇸
Veterans Affairs Medical Center - Brooklyn, Brooklyn, New York, United States
🇺🇸USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸Veterans Affairs Medical Center - Kansas City, Kansas City, Missouri, United States
S9415 Chemotherapy in Patients With Stage II or III Colon Cancer That Has Been Surgically Removed
- Conditions
- Colorectal Cancer
- Interventions
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2013-01-03
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 1135
- Registration Number
- NCT00002593
- Locations
- 🇺🇸
Emory University Hospital - Atlanta, Atlanta, Georgia, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸CentraCare Clinic, Saint Cloud, Minnesota, United States
S9714: Paclitaxel in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
- Conditions
- Lung Cancer
- First Posted Date
- 2004-08-24
- Last Posted Date
- 2012-07-24
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 60
- Registration Number
- NCT00002969
- Locations
- 🇺🇸
USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸CCOP - Atlanta Regional, Atlanta, Georgia, United States
🇺🇸Providence Hospital - Southfield, Southfield, Michigan, United States
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2018-08-10
- Lead Sponsor
- SWOG Cancer Research Network
- Target Recruit Count
- 8
- Registration Number
- NCT00088972
- Locations
- 🇺🇸
Ben Taub General Hospital, Houston, Texas, United States
🇺🇸Methodist Hospital, Houston, Texas, United States
🇺🇸Swedish Cancer Institute at Swedish Medical Center - First Hill Campus, Seattle, Washington, United States